Nimodipine-enhanced opiate analgesia in cancer patients requiring morphine dose escalation: a double-blind, placebo-controlled study

@article{Santilln1998NimodipineenhancedOA,
  title={Nimodipine-enhanced opiate analgesia in cancer patients requiring morphine dose escalation: a double-blind, placebo-controlled study},
  author={R. Santill{\'a}n and M. Hurl{\'e} and J. Armijo and Rosario de los Mozos and J. Fl{\'o}rez},
  journal={Pain},
  year={1998},
  volume={76},
  pages={17-26}
}
&NA; The ability of nimodipine, a dihydropyridine calcium antagonist, to reduce the daily dose of oral morphine in cancer patients who had developed dose escalation, was tested in 54 patients under randomized, double‐blind, placebo‐controlled conditions. We selected patients that required at least two successive increments of morphine to maintain pain relief. A possible pharmacokinetic interaction between nimodipine and morphine was also studied in 14 patients by assaying steady‐state serum… Expand
Perioperative Nimodipine and Postoperative Analgesia
Gabapentin Enhances the Analgesic Effect of Morphine in Healthy Volunteers
Adjuncts to opioid therapy
  • Fj Goldstein
  • Medicine
  • The Journal of the American Osteopathic Association
  • 2002
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 48 REFERENCES
Low-dose fentanyl analgesia modified by calcium channel blockers in cardiac surgery.
Calcium channel inhibitors suppress the morphine‐withdrawal syndrome in rats
Tolerance to opioid analgesics: clinical aspects.
Effect of Nifedipine on Morphine‐Induced Analgesia
...
1
2
3
4
5
...